Pain Control in Hospice Patients With Cancer-Related Pain
Opioid Titration in the Hospice Setting: Barriers Assessment and Modification of the Model Order Sheet and Protocol Stage 2, Part A
3 other identifiers
observational
22
1 country
1
Brief Summary
RATIONALE: Gathering information over time about cancer-related pain from patients in a hospice and their caregivers may help doctors learn more about pain control. PURPOSE: This clinical trial is studying how well standard pain control works in hospice patients with cancer-related pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jul 2007
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2007
CompletedFirst Submitted
Initial submission to the registry
February 6, 2008
CompletedFirst Posted
Study publicly available on registry
February 7, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2011
CompletedOctober 24, 2012
October 1, 2012
8 months
February 6, 2008
October 23, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Description of standard pain management methods and outcomes in the hospice setting
date on study to death
Study Arms (1)
Supportive Care
Alive Hospice Patients with Pain
Interventions
The Research Nurse will conduct a chart review after the patient's death.
The questionnaires will be completed at the end of week 1, week 2 and week 4.
Given to patient and caregivers throughout the study
Eligibility Criteria
Patients in Alive hospice who have pain and their caregivers.
You may qualify if:
- Patient eligibility includes:
- Alive Hospice outpatient
- Diagnosis of carcinoma
- Pain requiring fixed dose opioids
- Age \> 21 years
- Not pregnant or lactating
- Willing and able to sign informed consent -Able to speak/comprehend English
- Caregiver eligibility will include:
- Caregiver for an Alive Hospice patient
- Willing and able to sign informed consent
- Able to speak/comprehend English
You may not qualify if:
- PRIOR CONCURRENT THERAPY:
- Not specified
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Vanderbilt-Ingram Cancer Centerlead
- National Cancer Institute (NCI)collaborator
Study Sites (1)
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, 37232, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Barbara A. Murphy, MD
Vanderbilt-Ingram Cancer Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Medicine
Study Record Dates
First Submitted
February 6, 2008
First Posted
February 7, 2008
Study Start
July 1, 2007
Primary Completion
March 1, 2008
Study Completion
May 1, 2011
Last Updated
October 24, 2012
Record last verified: 2012-10